Did These 5 Stocks Miss or Beat Analyst Expectations?

ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) had a loss and missed Wall Street’s expectations, BUT beat the revenue expectation. Adjusted Earnings Per Share decreased to $-0.48 in the quarter versus EPS of $-0.19 in the year-earlier quarter. Revenue Was the same at $200,000 as the year-earlier quarter.

ZIOPHARM Oncology, Inc. reported adjusted EPS loss of $0.48 per share. By that measure, the company missed the mean analyst estimate of $-0.29. It beat the average revenue estimate of $0.